RaiseTrack

This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: investor relationships, two agreeing sources.

SereNeuro Therapeutics Pre-Seed (2026)

SereNeuro Therapeutics raised an undisclosed amount in a Pre-Seed round, listed in the Raise Track Update of 2026-10-06.

Company
SereNeuro Therapeutics
Round type
Pre-Seed
Date
2026-10-06
Industry
biotechnology
Location
Baltimore, MD

Summary

SereNeuro Therapeutics is listed in Section 1 of the Raise Track Update of 2026-10-06, which gives the round as Undisclosed (Pre-Seed). Investors named in the issue: not disclosed in the issue. The issue describes the company this way: A Baltimore, MD-based biotechnology company developing non-opioid therapies for pain raised an undisclosed amount in pre-seed funding. The company intends to use the funds to advance its lead program, SN101, toward Investigational New Drug (IND)-enabling activities and support its second program, SN102.

This page is not indexed by search engines yet. It is promoted once a second source, separate from the newsletter, confirms the round.

Investors

Sources

Last verified:

  1. https://www.finsmes.com/2026/10/sereneuro-therapeutics-closes-pre-seed-funding.html
    Type: reputable publication. Accessed 2026-10-12.
    Article linked from the Raise Track Update for 2026-10-06.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-06/
    Type: other verified public source. Accessed 2026-10-12.
    Raise Track Update for 2026-10-06, Section 1. Lists SereNeuro Therapeutics at Undisclosed (Pre-Seed) with investors: undisclosed.